Iron in CNS disease

Journal of Neuropathology and Experimental Neurology

Volumn 54, Issue 4, 1995, Pages 477-486

  Gelman, Benjamin B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

AIDS; Ferritin; Iron; Macrophage; Microglial cell; Oligodendrocyte; Parkinson's disease; Transferrin

Indexed keywords

FERRITIN; FREE RADICAL; IRON; IRON BINDING PROTEIN; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CATALYSIS; CELL RESPIRATION; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE ASSOCIATION; ELECTRON TRANSPORT; ENZYME ACTIVITY; HUMAN; IMAGE ANALYSIS; IRON BLOOD LEVEL; IRON KINETICS; MICROGLIA; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMAL; BRAIN CHEMISTRY; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM DISEASES; ELECTRON SPIN RESONANCE SPECTROSCOPY; GENE EXPRESSION REGULATION; HUMAN; IRON; IRON-BINDING PROTEINS; MAGNETIC RESONANCE IMAGING; MAGNETICS; METALLOPROTEINS; MYELIN SHEATH; NERVE DEGENERATION; OXIDATION-REDUCTION; RECEPTORS, TRANSFERRIN;

EID: 0029076828     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-199507000-00001     Document Type: Article

References (79)

1. Spatz H. Ober den Eisennachweis im Gehirn besonders in Zentren des extrapyramidalenmotorischen Systems. Z Ges Neurol Psychiatr 1922;77:261-390
2. Beard JL, Connor JR, Jones BC. Iron in the brain. Nutr Rev 1993;51:157-70
3. Connor JR, Benkovic SA. Iron regulation in the brain: Histochem ical, biochemical, and molecular considerations. Ann Neurol 1992;32:S51-S61
4. Halliwell B. Oxidants and the central nervous system: Some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol Scand 1989;126:23-33
5. Good PF, Olanow CW, Perl DP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study. Brain Res 1992;593:343-6
6. Jellinger K, Kienzl E, Rumpelmair G. Iron-melanin complex in substantia nigra of Parkinson's brains: An X-ray microanalysis. J Neurochem 1992;59:1168-71
7. Perl DP, Good PF. Comparative techniques for determining cellular iron distribution in brain tissues. Ann Neurol 1992;32:S76-S81
8. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. Magnetic resonance imaging of brain iron. Am J Neuroradiol 1986;7:373-80
9. O'Halloran TV. Transition metals in control of gene expression. Science 1993;261:715-25
10. Kemp JD. The role of iron and iron binding proteins in lymphocyte physiology and pathology. J Clin Immunol 1993;13:81-92
11. Wigglesworth JM, Baum H. Iron-dependent enzymes in the brain. In: Youdim MBH. Brain iron: Neurochemical and behavioral aspects. London: Taylor & Francis, 1988:25-66
12. Willmore LJ, Triggs WJ. Iron-induced lipid peroxidation and brain injury responses. Int J Dev Neurosci 1991;9:175-80
13. Theil EC. Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms. Ann Rev Biochem 1987;56:289-315
14. Octave J-N, Schneider Y-J, Trouet A, Crichton RR. Iron uptake and utilization by mammalian cells. I: Cellular uptake of transferrin iron. Trends Biochem Sci 1983;8:217-20
15. Dwork AJ, Schon EA, Herbert J. Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 1988;27:333-45
16. Morris CM, Candy JM, Oakley AE, Bloxam CA, Edwardson JA. Histochemical distribution of non-haem iron in the human brain. ActaAnat 1992;144:235-57
17. Hill JM, Ruff MR, Weber RJ, Pert CB. Transferrin receptors in rat brain: Neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci USA 1985;82:4553-7
18. Gerber MR, Connor JR. Do oligodendrocytes mediate iron regulation in the human brain? Neurology 1989;26:95-8
19. Levine SM, Macklin WB. Iron-enriched oligodendrocytes; a reexamination of their spatial distribution. J Neurosci Res 1990;26: 508-12
20. Francois C, Nguyen-Legros J, Percheron G. Topographical and cy-tological distribution of iron in cat and monkey brains. Brain Res 1981;215:317-22
21. Connor JR. Proteins of iron regulation in the brain in Alzheimer's disease. In: Randall B, ed. Iron and human disease. Boca Raton: Lauffer CRC Press Inc., 1992:365-90
22. Bracchi M, Savoiardo M, Triulzi F. Superficial siderosis of the CNS: MR diagnosis and clinical findings. Am J Neuroradiol 1993;14:227-36
23. Aisen P. Entry of iron into cells: A new role for the transferrin receptor in modulating iron release from transferrin. Ann Neurol 1992;32:S62-S68
24. Morris CM, Candy JM, Bloxham CA, Edwardson JA. Immunocy-tochemical localisation of transferrin in the human brain. Acta Anat 1992;143:14-18
25. Bloch B, Popovici T, Levin MJ, Tuil D, Kahn A. Transferrin gene expression visualized in oligodendrocytes of the rat brain using in situ hybridization and immunohistochemistry. Proc Natl Acad Sci USA 1985;82:6706-10
26. Connor JR, Fine RE. Development of transferrin-positive oligoden drocytes in the rat central nervous system. J Neurosci Res 1987; 17: 51-9
27. Connor JR, Phillips TM, Lakshman MR, Barron KD, Fine RE, Csiza CK. Regional variation in the levels of transferrin in the CNS of normal and myelin-deficient rats. J Neurochem 1987;49:1523-9
28. Connor JR, Fine RE. The distribution of transferrin immunoreac-tivity in the rat central nervous system. Brain Res 1986;368:319-28
29. Gelman BB, Rodriguez-Wolf MG, Wen J, Kumar S, Campbell GA, Herzog N. Siderotic cerebral macrophages in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1992;116:509-16
30. Roberts R, Sandra A, Sick GC, Lucas JJ, Fine RE. Studies of the mechanism of iron transport across the blood-brain barrier. Ann Neurol 1992;32:S43-S50
31. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 1992;31:327-35
32. Connor JR, Menzies SL, Saintt Martin SM, Mufson EJ. A histochem-ical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992;31:75-83
33. Tsutsumi M, Skinner MK, Sanders-Bush E. Transferrin gene expression and synthesis by cultured choroid plexus epithelial cells. J Biol Chem 1989;264:9626-31
34. Iancu TC. Ferritin and hemosiderin in pathological tissues. Electron Microsc Rev 1992;5:209-29
35. Boyd D, Vecoli C, Belcher DM, Jain SK, Drysdale JW. Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 1985;260:11755-61
36. Kaneko Y, Kitamoto T, Tateishi J, Yamaguchi K. Ferritin immu-nohistochemistry as a marker for microglia. Acta Neuropathol 1989;79:129-36
37. Gelman BB. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol 1993;34: 65-70
38. Koeppen AH, Dickson AC, Chu RC, Thach RE. The pathogenesis of superficial siderosis of the central nervous system. Ann Neurol 1992;34:646-53
39. Cooper PJ, Iancu TC, Ward RJ, Gutteridge KM, Peters TJ. Quantitative analysis of immunogold labelling for ferritin in liver from control and iron-overloaded rats. Histochem J 1988;20:499-509
40. Richter GW. Studies of iron overload. Rat liver siderosome ferritin. Lab Invest 1984;50:26-35
41. Munro H. The ferritin genes: Their response to iron status. Nutr Rev 1993;51:65-73
42. Patino MM, Walden WE. Cloning of a functional cDNA for the rabbit ferritin mRNA repressor protein. Demonstration of a tissue-specific pattern of expression. J Biol Chem 1992;267:19011-16
43. White K, Munro HN. Induction of ferritin synthesis by iron is regulated at both transcriptional and translational levels. J Biol Chem 1988;263:8938-42
44. Testa U, Kuehn L, Petrini M, Quaranta MT, Pelosi E, Peschie C. Differential regulation of iron regulatory element-binding protein(s) in cell extracts of activated lymphocytes versus monocytes-macrophages. J Biol Chem 1991;266:13925-30
45. Neckers LM, Cossman J. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci USA 1983;80:3494-8
46. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM. Iron independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci USA 1991;88:4946-50
47. Wei Y, Miller SC, Tsuji Y, Torti SV, Torti FM. Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem Biophys Res Commun 1990;169:289-96
48. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN. Translational control during the acute phase response; ferritin synthesis in response to interleukin-1. J Biol Chem 1990;265: 14572-8
49. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397-9
50. Hartung HP, Schafer B, Heininger K, Toyka KV. Suppression of experimental autoimmune neuritis by the oxygen radical scavenger superoxide dismutase and catalase. Ann Neurol 1988;23:453-60
51. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in MS. Am J Neuroradiol 1987;8:413-19
52. Dickinson TK, Connor JR. Histological analysis of selected brain regions of hypotransferrinemic mice. Brain Res 1994;635:169-78
53. Jellinger KA, Kienzl E, Rumpelmaier G, et al. Iron and ferritin in substantia nigra in Parkinson's disease. Adv Neurol 1993;60: 267-72
54. Antonino A, Leenders KL, Meier D, Oertel WH, Boesider P, An-liker M. T2 relaxation time in patients with Parkinson's disease. Neurology 1993;43:697-700
55. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann Neurol 1992;32:804-12
56. Sian J, Dexter DT, Lees AJ, Daniel S, Jenner P, Marsden CD. Glu-tathione-related enzymes in brain in Parkinson's disease. Ann Neurol 1994;36:356-61
57. Cohen G. The brain on fire? Ann Neurol 1994;36:333
58. Griffiths PD, Crossman AR. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 1993;4:61-5
59. Dexter DT, Sian J, Rose S. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 1994;35:38-44
60. Riederer J, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. Neurochemistry 1989;52: 515-20
61. Aime S, Fasano M, Bergamasco B, Lopiano L, Valente G. Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. J Neurochem 1994;62:369-71
62. Dexter DT, Jenner P, Schapira AHV, Marsden CD. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 1992;32:S94-S100
63. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-93
64. Savoiardo M, Halliday WC, Nardocci N. Hallervorden-Spatz disease: MR and pathologic findings. Am J Neuroradiol 1993; 14: 155-62
65. Ito M, Okuno T, Asato R, et al. MRI in infantile neuroaxonal dystrophy. Pediatr Neurol 1989;5:245-8
66. Kawamata T, Tooyama I, Yamada T, Walker DG, McGeer PL. Lac-totransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 1993;142:1574-85
67. Good PF, Perl DP, Bierer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study. Ann Neurol 1992;31: 286-92
68. Selkoe DJ. Alzheimer's disease: A central role for amyloid. J Neu-ropathol Exp Neurol 1994;53:438-47
69. Zubenko GS, Farr J, Stiffler JS, Hughes HB, Kaplan BB. Clinically silent mutation in the putative iron-responsive element in exon 17 of the beta-amyloid precursor protein gene. J Neuropathol Exp Neurol 1992;51:459-63
70. Bodovitz S, Falduto M, Frail DE, Klein WL. Iron levels modulate a-secretase cleavage of amyloid precursor protein. Soc Neurosci Abstr 1994;20:1244
71. Koeppen AH, Hurwitz CG, Dearborn RE. Experimental superficial siderosis of the central nervous system: Biochemical correlates. J Neurol Sci 1992;112:38-35
72. Worrall M, Worwood M. Immunological properties of ferritin during in vitro maturation of human monocytes. Eur J Haematol 1991;47:223-8
73. Fuchs D, Hausen A, Reibnegger G, et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 1991;46:65-70
74. Perrella O, Finelli L, Munno I, Parrella A, Soscia E, Carrieri PB. Cerebrospinal fluid ferritin in human immunodeficiency virus infection: A marker of neurologic involvement? J Infect Dis 1993;168:1079-80
75. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-82
76. Achim CL, Wang R, Miners DK, Wiley CA. Brain viral burden in HIV infection. J Neuropathol Exp Neurol 1994;53:284-94
77. Yoshioka M, Shapshak P, Sun NCJ, et al. Simultaneous detection of ferritin and HIV-1 in reactive microglia. Acta Neuropathol 1992;84:297-306
78. Ameglio F, Tilocca F, Area MV, Alemanno L, Dole A. Ferritin downregulation in HIV-infected cells. AIDS Res Hum Retrovir 1993;8:795-8
79. Recht L, Torres CO, Smith TW, Rasco V, Griffin TW. Transferrin receptor in normal and neoplastic brain tissue: Implication for brain-tumor immunotherapy. J Neurosurg 1990;72:941-5